Susceptibility of Staphylococcus aureus bacteremia strains to different skin-derived antimicrobial proteins

Area of Science:

• Microbiology
• Immunology
• Dermatology

Background:

• Staphylococcus aureus is a significant pathogen causing skin infections and severe bacteremia.
• Innate immunity, including antimicrobial peptides (AMPs) like human beta-defensin-3 and RNase 7, controls S. aureus on the skin.
• A compromised skin barrier may facilitate S. aureus invasion.

Purpose of the Study:

• To investigate if S. aureus strains from bacteremia patients exhibit reduced susceptibility to skin-derived AMPs compared to strains from healthy individuals.
• To test the hypothesis that decreased AMP susceptibility in S. aureus contributes to invasive infections.

Main Methods:

• Collected S. aureus strains from patients with bacteremia and healthy carriers.
• Assessed the susceptibility of these strains to killing by various skin-derived AMPs in vitro.

Main Results:

• No significant difference was observed in the antimicrobial activity of skin-derived AMPs against S. aureus strains from bacteremia patients versus control strains.
• The killing efficacy of AMPs was comparable between the two groups of S. aureus isolates.

Conclusions:

• The susceptibility of S. aureus to skin-derived AMPs does not appear to be a determining factor in the development of bacteremia.
• The emergence of S. aureus bacteremia is likely not driven by variations in resistance to the skin's innate antimicrobial defenses.